References
- Serjeant GR, Serjeant BE. Sickle Cell Disease. Oxford, UK: Oxford University Press, 2001
- National Heart, Lung and Blood Institute. Sickle cell anemia, key points. http://www.nhlbi.nih.gov/health//dci/Diseases/Sca/SCA_Summary.html (accessed December 10 2013)
- Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996;13(5):501–512
- Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010;115(26):5300–5311
- Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11–16
- Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303(13):1288–1294
- Hemker BG, Brousseau DC, Yan K, et al. When children with sickle-cell disease become adults: Lack of outpatient care leads to increased use of the emergency department. Am J Hematol. 2011;86(10):863–865
- Raphael JL, Shetty PB, Liu H, et al. A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: Opportunities to improve healthcare quality. Pediatr Blood Cancer. 2008;51(5):647–651
- Zielinski A, Borgquist L, Halling A. Distance to hospital and socioeconomic status influence secondary health care use. Scand J Prim Health Care. 2013;31(2):83–88
- Billi JE, Pai CW, Spahlinger DA. The effect of distance to primary care physician on health care utilization and disease burden. Health Care Manage Rev. 2007;32(1):22–29
- Buchanan RJ, Stuifbergen A, Chakravorty BJ, et al. Urban/rural differences in access and barriers to health care for people with multiple sclerosis. J Health Hum Serv Admin. 2006;29(3):360–375
- Sibley LM, Weiner JP. An evaluation of access to health care services along the rural-urban continuum in Canada. BMC Health Serv Res. 2011;11:20
- Skinner AC, Slifkin RT. Rural/urban differences in barriers to and burden of care for children with special health care needs. J Rural Health. 2007;23(2):150–157
- Andemariam B, Owarish-Gross J, Grady J, et al. Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care. Pediatr Blood Cancer. 2014;61(4):697–701
- Frome EL. The analysis of rates using Poisson regression models. Biometrics. 1983;39(3):665–674
- Frome EL, Checkoway H. Epidemiologic programs for computers and calculators. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol. 1985;121(2):309–323
- Lash T, Matthew P, Fink AK. Applying Quantitative Bias Analysis to Epidemiologic Data. New York, NY: Springer New York, 2009
- Nottage KA, Hankins JS, Smeltzer M, et al. Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. PloS One. 2013;8(8):e72077. doi: 10.1371/journal.pone.0072077
- Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778):1663–1672
- Mueller BU. When should hydroxyurea be used for children with sickle cell disease? Pediatrics. 2008;122(6):1365–1366